Interim report January – March 2006

• Net sales in the first quarter 2006 increased by 68 percent and amounted to 120.6 MSEK (72.0). The pro-forma sales increase was approx. 9 percent at comparable exchange rates. • The operating result for the first quarter improved by 10 MSEK and amounted to –12.2 MSEK (-22.2). • The result after tax for the first quarter amounted to -20.8 MSEK (-13.5). • Earnings per share in the first quarter amounted to -0.24 SEK (-0.21). • The Group net financial income has been charged with unrealized exchange gains relating to long-term receivables from foreign subsidiaries to the amount of -5.3 MSEK (9.5). • In January exclusive distribution, production and further development rights to Vapourtec’s solvent evaporation system V-10 were acquired. • As previously announced, Torben Jörgensen will succeed Jeff Bork as president and CEO at today’s General Meeting. • In accordance with an authorization from the Annual General Meeting held on April 27, 2005, a global option program for the Group’s employees – Biotage AB Global Share Option Plan 2005 – has been adopted. Contact: Jeff Bork, President and CEO Tel: +46 734 22 16 60 Torben Jörgensen, new President and CEO Tel: +46 70 749 0584 Mats-Olof Wallin, CFO Tel: +46 705 93 52 73 Biotage AB Kungsgatan 76 SE-753 18 Uppsala Tel:+46 18 565900 www.biotage.com Org No 556539-3138